The Cancer Consortium provides a variety of funding opportunities for the purpose of supporting existing members and recruiting new ones, with the ultimate goal of stimulating innovative cancer research. Opportunities include Pilot Awards, New Investigator Awards, and Catchment Area Health Pilot Awards.
Consortium developmental awards are funded through a combination of Cancer Center Support Grant (CCSG) funds and philanthropic donations. Applications for each award are evaluated by a committee of Consortium faculty reviewers.
Eligibility and application requirements are different for each award. For more information, please review the description and RFA for each individual award.
Consortium members are automatically notified of new funding opportunities, including CCSG administrative supplements. If you are not a member and would like to stay informed about current funding opportunities, please email amiller2@fredhutch.org to be added to the Consortium newsletter.
Cancer Consortium Pilot Awards
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium (“The Consortium”) Cancer Center Support Grant (CCSG) to support cancer-related pilot projects. This competition will provide awards of up to $100,000 direct costs (plus F&A/indrect costs as allowable) for one year of pilot project support.
- Pilot funding eligibility is restricted to Consortium members. For additional eligibility criteria, see the "Application Process" section of the RFA.
- There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged. Also included in this competition are two categories targeted as areas of special interest to the Consortium: Health Disparities research and Cross-Disciplinary Translational research.
Release date: January 2, 2025
Due date: February 14, 2025
Request for Applications - 2025 Cancer Consortium Pilot Awards
Follow the instructions in the RFA to submit your application via InfoReady.
Questions? Please contact cancerconsortium@fredhutch.org.
New Investigator Award
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium ("The Consortium") Cancer Center Support Grant (CCSG) to provide developmental support to new or junior faculty who are establishing their research within the Consortium. These funds provide a flexible source of funding designed to allow new investigators to work toward obtaining future, independent research funding. Departments are also eligible to apply for this funding to support new faculty being hired by a Consortium institution.
This competition will provide two to three awards of up to $100,000 direct costs each (plus F&A/indirect costs).
In order to be eligible for this award, applicants must meet one or more of the following requirements:
- Consortium members or those eligible to become a member at the time of award. To view detailed membership criteria or apply, click here.
- Assistant Professor level or higher who have begun their appointment at one of the Consortium institutions (Fred Hutch, University of Washington, Seattle Children’s) on or after July of 2022.
- New faculty being recruited who will meet Consortium membership criteria at the time of the award start date (July 1, 2025).
Faculty who meet the following criteria are NOT eligible for this award:
- Faculty who have received a CCSG-funded award of any kind OR a pilot award funded by Safeway or the Hite Foundation within three years of the application deadline (since June 2022).
- Investigators who are PIs on R01, P01, or P50 grants.
- Consortium members in acting faculty positions and faculty with Consortium Affiliate memberships.
All research proposals must be cancer-focused. Financial need will be taken into consideration for those who did not receive substantial research funds as part of their negotiatied start-up package.
Release date: April 1, 2025
Due date: May 16, 2025, by 5:00pm
For additional information and detailed application instructionss, please see the attached RFA:
Request for Applications – 2025 Cancer Consortium New Investigator Awards
Applications are to be submitted using InfoReady.
Contact cancerconsortium@fredhutch.org with any questions.
Catchment Area Health Pilot Awards
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium ("the Consortium") Cancer Center Support Grant (CCSG) and non-sponsored funds to support new cancer-related pilot projects focused on the Consortium’s catchment area, which includes the entire state of Washington. Please see pages 1-2 of RFA (linked below) for more information about the cancer burden in the catchment area.
The research plan should address research on cancers relevant to the catchment area and/or the populations that face the highest burden or cancer disparities in the state. This competition will fund one project, at a maximum of up to $100,000 in direct costs (plus F&A/indirect costs), for one year.
Consortium members are eligible for this pilot funding. Only eligible applicants may serve as the Principal Investigator on the pilot applicaiton; however, non-Consortium members and affiliate members may be involved on the project as collaborators. Consortium members who have received a CCSG-funded award of any kind (including a Safeway award) within three years of the anticipated start date of April 1, 2025, are not eligible to apply.
Release date — January 2, 2025
Due date — February 14, 2025
For additional information about the award, eligibility, and the application process, please see the attached RFA:
Request for Applications - 2025 Cancer Consortium Catchment Area Health Pilot Award
Applications should be submitted through InfoReady.
Contact the Office of Community Outreach and Engagement (OCOE) at EndDisparities@FredHutch.org with any questions.
Safeway Pilot Awards
Funds are available from Safeway, Inc. to support cancer-related pilot projects with awards of at least $80,000 direct costs (F&A not included) for one year of pilot project support. Fred Hutch early career investigators who are Consortium members are eligible for this funding opportunity.
There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged.
- Fred Hutch early career investigators who are Consortium members are eligible for this funding opportunity. Information and instructions on how to join the Cancer Consortium can be found here.
- There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged.
More details about the application process can be found in the RFA.
Release date — September 26, 2022
Due date — October 21, 2022 at 5 pm
Request for Applications - 2022 Cancer Consortium Pilot Awards (PDF)
Request for Applications - 2022 Cancer Consortium Pilot Awards (Word)
Applications are to be submitted as one complete PDF file to: cancerconsortium@fredhutch.org
Contact Kris Blair, Research Development Specialist, with questions at kblair@fredhutch.org.
Survivorship Pilot Award
The Survivorship Program invites proposals of high impact and innovation that will promote new research directions focused on cancer survivors. The goal of this award is to stimulate cross-institutional collaborations (Fred Hutch, University of Washington, Seattle Children’s) and/or new collaborations between Consortium investigators who have not previously worked together.
For additional information, click here to view the full RFA for the Cancer Consortium Survivorship Research Pilot Award.
- At least one of the primary investigators should be a Cancer Consortium investigator (https://www.cancerconsortium.org/en/membership.html).
- Priority will be given to applications that center on cross-institutional collaborations (investigators with primary appointments at different Consortium partners) and/or new collaborations (which can be among investigators based at the same Consortium partner but who have no previously co-funded work and no significant non-funded prior collaborations).
- Priority will be given to investigators who have not previously received a Survivorship Pilot award.
- A member of the application team will be asked to pitch their proposal at the Late Effects & Survivorship Seminar on January 9, 2025 (1 to 3pm).
Due date: December 31, 2024
Awardees will be announced no later than February 1, 2025.
Submit as a PDF file labeled with your last names and shortened title containing the following information to Emily Artim (erajotte@fredhutch.org):
- Project Title, Investigator Names, Institutional Positions, with brief explanation of how this represents a cross-institutional collaboration and/or new collaboration (if relevant)
- Proposal (limited to 2 pages, NIH formatting rules), including as appropriate: Background (i.e., significance/innovation), Aims and Hypotheses, Approach (any preliminary data [not required], study design, statistical considerations [highly encouraged]), and Future Plans (i.e., how will this award lead to new grants)
- Any tables and figures (limited to 1 additional page)
- References (limited to 1 additional page)
- Investigator biosketches (NIH format)
Contact Dr. Eric Chow, Co-Director of the Fred Hutch Survivorship Program (ericchow@uw.edu) with any questions.
Trainee Travel Award
The Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium offers a Trainee Travel Award that is available to postdoctoral fellows, graduate students, and medical fellows whose faculty advisor is a member of the Consortium. Faculty members can be found using the Consortium's Member Search feature. The scholarship can be applied to registration, travel, and accommodation costs for any conference that will further trainee professional development. The award competition opens in January.
For additional questions, you may reach the Office of Education and Training at OET@fredhutch.org.
Pilot Award
| Member | Research Program | Award Institution |
| James Alvarez, PhD^^ | Breast & Ovary Cancers | FH |
| Evan Newell, PhD | Cancer Immunology | FH |
| Anthony Rongvaux, PhD | Cancer Immunology | FH |
| Elizabeth Swisher, MD++ | Breast & Ovary Cancers | UW |
Lisa Tachiki, MD^^ | Cancer Immunology | UW |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary
New Investigator Award
| Member | Research Program | Award Institution |
| Kaitlyn Fladeboe, PhD | Cancer Epidemiology, Prevention & Control | SC |
| Christopher Lapointe, PhD | Cancer Basic Biology | FH |
| Xueqiu Lin, PhD | Biostatistics & Computational Biology | FH |
| Sanjay Srivatsan, PhD | Cancer Basic Biology | FH |
Alexi Vasbinder, PhD, RN | Cancer Epidemiology, Prevention & Control | UW |
| Claudia Vasquez, PhD | Cancer Basic Biology | UW |
Pilot Award
| Member | Research Program | Award Institution |
Barbara Baquero, PhD, MPH** | Cancer Epidemiology, Prevention & Control | UW |
Taran Gujral, PhD^^ | Prostate Cancer | FH |
Michael Haffner, MD, PhD^^ | Prostate Cancer | FH |
Hao Yan Kueh, PhD | Cancer Basic Biology | UW |
Surojit Sarkar, PhD | Cancer Immunology | SC |
| Megan Shen, PhD | Cancer Epidemiology, Prevention & Control | FH |
| Arvind Rasi Subramaniam, PhD | Cancer Basic Biology | FH |
| Kate Markey, MBBS, MClin Res, PhD | Hematologic Malignancies | FH |
| Arjee Restar, PhD, MPH** | Cancer Epidemiology, Prevention & Control | UW |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary
New Investigator Award
| Member | Research Program | Award Institution |
Myron Evans, PhD | Cancer Basic Biology | SC |
Jennifer Kong, PhD | Cancer Basic Biology | UW |
Devin Schweppe, PhD | Cancer Basic Biology | UW |
| Joshua Veatch, MD, PhD | Non-Programmatically Aligned | FH |
Pilot Award
| Member | Research Program | Award Institution |
Kemi Doll, MD, MCSR**^^ | Breast & Ovary Cancers | UW |
Philip Greenberg, MD^^ | Cancer Immunology | FH |
Heather Greenlee, ND, PhD, MPH^^ | Cancer Epidemiology, Prevention & Control | FH |
Patrick Paddison, PhD | Cancer Basic Biology | FH |
Raymond Yeung, MD, FRCS(C), FACS^^ | Other Oncology | UW |
| Burcu Darst, PhD++ | Prostate Cancer | FH |
Safeway Pilot Award
| Member | Research Program | Award Institution |
Susan Bullman, PhD | Pathogen Associated Malignancies | FH |
Melody Campbell, PhD | Hematologic Malignancies | FH |
| Meghan Koch, PhD | Pathogen Associated Malignancies | FH |
| Christina Termini, PhD | Hematologic Malignancies | FH |
New Investigator Award
| Member | Research Program | Award Institution |
Richard Adeyemi, DVM, PhD | Breast & Ovary Cancers | FH |
Brittany Barber, MD, MSc, FRCSC | Other Oncology | UW |
Thelma Escobar, PhD | Cancer Basic Biology | UW |
Benham Nabet, PhD | Cancer Basic Biology | FH |
Yaw Nyame, MD, MS, MBA | Prostate Cancer | UW |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Crosss Disciplinary
Pilot Award
| Member | Research Program | Award Institution |
Neelendu Dey, MD++ | Pathogen Associated Malignancies | FH |
Maitreya Dunham, PhD | Cancer Basic Biology | UW |
Mark Headley, PhD | Cancer Immunology | FH |
David Hockenbery, MD++ | Cancer Basic Biology | FH |
David MacPherson, PhD | Cancer Basic Biology | FH |
Margaret M. Madeleine, MPH, PhD** | Pathogen Associated Malignancies | FH |
Manoj Menon, MD, MPH++ | Pathogen Associated Malignancies | FH |
Evan Newell, PhD | Cancer Immunology | FH |
Lawrence D. True, MD^^ | Prostate Cancer | UW |
New Investigator Award
| Member | Research Program | Award Institution |
Kalyan Banda, MD | Breast & Ovary Cancers | UW |
Kevin Barry, PhD | Cancer Immunology | FH |
Nicolas Lehrbach, PhD | Cancer Basic Biology | FH |
Shannon Oda, PhD | Cancer Immunology | SC |
Shivani Srivastava, PhD | Cancer Immunology | FH |
Diane Tseng, MD, PhD | Other Oncology | UW |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary
Pilot Award
| Member | Research Program | Award Institution |
Marianne Dubard-Gault, MD**++ | Other Oncology | UW |
Teresa Hyun MD, PhD^^ ++ | Hematologic Malignancies | FH |
Savannah Partridge, PhD | Breast & Ovary Cancers | UW |
Kerryn Reding, PhD, MPH^^ | Cancer Epidemiology, Prevention & Control | UW |
Parth Shah, PharmD, PhD++ | Cancer Epidemiology, Prevention & Control | FH |
Alpana Waghmare, MD | Hematologic Malignancies | SC |
Safeway Pilot Award
| Member | Research Program | Award Institution |
Stacey Cohen, MD | Other Oncology | UW |
Brandon Hadland, MD, PhD | Hematologic Malignancies | FH |
Michael Haffner, MD, PhD | Prostate Cancer | FH |
Natasha Hunter, MD** | Breast & Ovary Cancers | UW |
Stanley Lee, PhD^^ | Hematologic Malignancies | FH |
Yasemin Sancak, PhD | Other Oncology | UW |
New Investigator Award
| Member | Research Program | Award Institution |
Brandon Dyer, MD | Other Oncology | UW |
Julie Mathieu, PhD | Cancer Basic Biology | UW |
Jeff Rasmussen, PhD | Cancer Basic Biology | UW |
Lucas Sullivan, PhD | Cancer Basic Biology | FH |
Trang VoPham, PhD, MS, MPH | Cancer Epidemiology, Prevention & Control | FH |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary
Pilot Award
| Member | Research Program | Award Institution |
Shreeram Akilesh, MD, PhD | Cancer Basic Biology | UW |
Rachel Ceballos, PhD** | Cancer Epidemiology, Prevention & Control | FH |
Eric Chow, MD, MPH++ | Hematologic Malignancies | FH |
Safeway Pilot Award
| Member | Research Program | Award Institution |
Taran Gujral, PhD | GI Cancer/Prostate Cancer | FH |
Anna Halpern, MD | Hematologic Malignancies | UW |
Salene Jones, PhD | Cancer Epidemiology, Prevention & Control | FH |
Scott Kennedy, PhD | Cancer Basic Biology | UW |
John Lee, MD, PhD | Prostate Cancer | FH |
Kathryn Lowry, MD | Cancer Epidemiology, Prevention & Control | UW |
Parth Shah, PharmD, PhD**^^ | Cancer Epidemiology, Prevention & Control | FH |
David Shechner, PhD | Cancer Basic Biology | UW |
New Investigator Award
| Member | Research Program | Award Institution |
Susan Bullman, PhD | Global Oncology | FH |
Heather Gustafson, PhD | Cancer Immunology | SC |
Gavin Ha, PhD | Biostatistics & Computational Biology | FH |
Teresa Kim, MD | Other Oncology | UW |
Early Phase Clinical Research Support
| Member | Research Program | Award Institution |
Eric Huang, MD, PhD | Other Oncology | UW |
Sarah Psutka, MD | Prostate Cancer | UW |
Roland Walter, MD, PhD, MS | Hematologic Malignancies | UW |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary
Pilot Award
| Member | Research Program | Award Institution |
Jonathan Bricker, PhD** | Cancer Epidemiology, Prevention & Control | FH |
Luis Ceze, PhD | Cancer Basic Biology | UW |
Eleanor Chen, MD, PhD | Cancer Basic Biology | UW |
John Gore, MD++ | Prostate Cancer | UW |
Janie Lee, MD++ | Cancer Epidemiology, Prevention & Control | UW |
Karen Syrjala, PhD^^ | Hematologic Malignancies | FH |
Raymond Yeung, MD, FRCS(C), FACS^^ | GI Cancer | UW |
Safeway Pilot Award
| Member | Research Program | Award Institution |
Slobodan Beronja, PhD | Cancer Basic Biology | FH |
Cole DeForest, PhD^^ | Cancer Basic Biology | UW |
VK Gadi, MD, PhD^^ | Women’s Cancer | FH |
Liangcai Gu, PhD | Cancer Basic Biology | UW |
Andrea Hartzler, PhD | Prostate Cancer | UW |
Jaimee Heffner, PhD++ | Cancer Epidemiology, Prevention & Control | FH |
James Park, MD^^ | GI Cancer | UW |
Supriya Saha, MD | GI Cancer | FH |
New Investigator Award
| Member | Research Program | Award Institution |
Neelendu Dey, MD | GI Cancer | FH |
Rachel Issaka, MD | Cancer Epidemiology, Prevention & Control | FH |
Vandana Kalia, PhD | Immunology & Vaccine Development | SC |
Masaoki Kawasumi, MD, PhD | Cancer Basic Biology | UW |
Bo Yu, MD | Women’s Cancer | UW |
Early Phase Clinical Research Award
| Member | Research Program | Award Institution |
William DePaolo, PhD | GI Cancer | UW |
Phuong Vo, MD | Hematologic Malignancies | FH |
** Health Disparities Focus
++ Catchment Area Pilot
^^ Cross Disciplinary